Kenneth J Widder - Net Worth and Insider Trading

Kenneth J Widder Net Worth

The estimated net worth of Kenneth J Widder is at least $66,191 dollars as of 2024-06-02. Kenneth J Widder is the Director of Evoke Pharma Inc and owns about 132,381 shares of Evoke Pharma Inc (EVOK) stock worth over $66,191. Details can be seen in Kenneth J Widder's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kenneth J Widder has not made any transactions after 2017-02-22 and currently still holds the listed stock(s).

Transaction Summary of Kenneth J Widder

To

Kenneth J Widder Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kenneth J Widder owns 3 companies in total, including Evoke Pharma Inc (EVOK) , QuidelOrtho Corp (QDEL) , and Personalis Inc (PSNL) .

Click here to see the complete history of Kenneth J Widder’s form 4 insider trades.

Insider Ownership Summary of Kenneth J Widder

Ticker Comapny Transaction Date Type of Owner
EVOK Evoke Pharma Inc 2017-02-22 director & 10 percent owner
QDEL QuidelOrtho Corp 2022-05-27 director
PSNL Personalis Inc 2023-06-13 director

Kenneth J Widder Latest Holdings Summary

Kenneth J Widder currently owns a total of 1 stock. Kenneth J Widder owns 132,381 shares of Evoke Pharma Inc (EVOK) as of February 22, 2017, with a value of $66,191.

Latest Holdings of Kenneth J Widder

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EVOK Evoke Pharma Inc 2017-02-22 132,381 0.50 66,191

Holding Weightings of Kenneth J Widder


Kenneth J Widder Form 4 Trading Tracker

According to the SEC Form 4 filings, Kenneth J Widder has made a total of 0 transactions in Evoke Pharma Inc (EVOK) over the past 5 years. The most-recent trade in Evoke Pharma Inc is the acquisition of 37,500 shares on February 22, 2017, which cost Kenneth J Widder around $1 Million.

Insider Trading History of Kenneth J Widder

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kenneth J Widder Trading Performance

GuruFocus tracks the stock performance after each of Kenneth J Widder's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kenneth J Widder is -18.13%. GuruFocus also compares Kenneth J Widder's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kenneth J Widder within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kenneth J Widder's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kenneth J Widder

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -11.56 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -10.95 LIMIT LIMIT LIMIT LIMIT LIMIT

Kenneth J Widder Ownership Network

Ownership Network List of Kenneth J Widder

No Data

Ownership Network Relation of Kenneth J Widder

Insider Network Chart

Kenneth J Widder Owned Company Details

What does Evoke Pharma Inc do?

Who are the key executives at Evoke Pharma Inc?

Kenneth J Widder is the director & 10 percent owner of Evoke Pharma Inc. Other key executives at Evoke Pharma Inc include director & President and CEO David A Gonyer , Exec VP & Chief Bus. Officer Matthew J D'onofrio , and 10 percent owner Lvp Gp Iii, Llc .

Evoke Pharma Inc (EVOK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Evoke Pharma Inc (EVOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Evoke Pharma Inc (EVOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Evoke Pharma Inc (EVOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Evoke Pharma Inc Insider Transactions

No Available Data

Kenneth J Widder Mailing Address

Above is the net worth, insider trading, and ownership report for Kenneth J Widder. You might contact Kenneth J Widder via mailing address: 10070 Barnes Canyon Road, San Diego Ca 92121.

Discussions on Kenneth J Widder

No discussions yet.